Adalim, Adelia M.

HRN: 14-53-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
CO-AMOXICLAV 625MG (TAB)
07/23/2026
07/29/2026
PO
625mg
Q8h
UTI Following Delivery
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: